Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol

This study has been completed.

Sponsor:

Collaborator:

Stanley Medical Research Institute

Information provided by:

Ambulatório de Bipolaridade

ClinicalTrials.gov Identifier:

NCT00740259

First received: August 20, 2008

Last updated: NA

Last verified: August 2008

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Primary Completion Date:	May 2007 (Final data collection date for primary outcome measure)

No publications provided by Ambulatório de Bipolaridade

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bisol LW, Brunstein MG, Ottoni GL, Ramos FL, Borba DL, Daltio CS, de Oliveira RV, Paz GE, de Souza SE, Bressan RA, Lara DR. Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia. J Clin Psychiatry. 2008 Oct;69(10):1572-9. Epub 2008 Sep 23.

To Top